Novo's New Drug Shows Promise in Phase II Diabetes Trials | Retatrutide News

Novo Nordisk has reported positive Phase II trial results for a new Type 2 diabetes drug. This development challenges Eli Lilly's Retatrutide in the GLP...
Clinical Trials · October 27, 2026